Each filer's latest filing for 09077A106 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
CVI Investments, Inc.
13G/A
|
9.9% |
2/17/2026
Event 12/31/2025
|
||
| CVI Investments, Inc. | 9.9% | |||
| Heights Capital Management, Inc. | 9.9% | |||
| Blue Owl Capital Holdings LP 13G | 5.9% |
2/12/2026
Event 12/31/2025
|
||
| Janus Henderson Group PLC 13G | 5.0% |
12/8/2025
Event 11/28/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Baker Bros. Advisors LP
13G/A
|
4.0% |
2/14/2025
Event 12/31/2024
|
||
| Baker Bros. Advisors LP | 4.0% | |||
| Baker Bros. Advisors (GP) LLC | 4.0% | |||
| Julian C. Baker | 4.0% | |||
| Felix J. Baker | 4.0% | |||
| Rainer M. Erdtmann 13G/A | 3.9% |
2/6/2026
Event 12/31/2025
|
||
|
Cormorant Asset Management, LP
13D/A
|
1.5% |
10/24/2025
Event 10/22/2025
|
||
| Cormorant Global Healthcare Master Fund, LP | 0.7% | |||
| Cormorant Global Healthcare GP, LLC | 0.7% | |||
| Cormorant Private Healthcare Fund III LP | 0.7% | |||
| Cormorant Private Healthcare GP III, LLC | 0.7% | |||
| Cormorant Asset Management, LP | 1.4% | |||
| Chen Bihua | 1.5% | |||
| BlackRock, Inc. 13G/A | 1.3% |
7/16/2025
Event 6/30/2025
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 70 | 26.8 M | $35.3M |
| 2026 Q2 | 62 | 25.3 M | $36.8M |
| 2026 Q1 | 65 | 24.4 M | $37.2M |
| 2025 Q4 | 63 | 23.2 M | $28.8M |
| 2025 Q3 | 77 | 25.1 M | $50.6M |
| 2025 Q2 | 93 | 28.7 M | $51.7M |
| 2025 Q1 | 101 | 21.4 M | $47.2M |
| 2024 Q4 | 117 | 23.0 M | $89.3M |
| 2024 Q3 | 94 | 23.4 M | $237M |
| 2024 Q2 | 111 | 23.6 M | $106M |
| 2024 Q1 | 111 | 31.2 M | $466M |
| 2023 Q4 | 107 | 27.9 M | $405M |
| 2023 Q3 | 88 | 30.1 M | $414M |
| 2023 Q2 | 99 | 29.6 M | $649M |
| 2023 Q1 | 76 | 23.4 M | $727M |
| 2022 Q4 | 56 | 14.5 M | $122M |
| 2022 Q3 | 51 | 14.8 M | $145M |
| 2022 Q2 | 43 | 17.0 M | $204M |
| 2022 Q1 | 51 | 18.2 M | $81.2M |
| 2021 Q4 | 50 | 17.1 M | $127M |
| 2021 Q3 | 40 | 17.1 M | $205M |
| 2021 Q2 | 45 | 16.5 M | $254M |